PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $344,500 | -7.0% | 325,000 | +33.4% | 0.00% | – |
| Q4 2022 | $370,424 | -28.4% | 243,700 | 0.0% | 0.00% | – |
| Q3 2022 | $517,000 | +58.1% | 243,700 | 0.0% | 0.00% | – |
| Q2 2022 | $327,000 | -29.5% | 243,700 | +10.8% | 0.00% | – |
| Q1 2022 | $464,000 | -39.1% | 220,000 | +7.2% | 0.00% | – |
| Q4 2021 | $762,000 | -25.6% | 205,300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,024,000 | -21.9% | 205,300 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $1,311,000 | +12.2% | 201,100 | +18.6% | 0.00% | 0.0% |
| Q1 2021 | $1,168,000 | -26.1% | 169,500 | +9.4% | 0.00% | 0.0% |
| Q4 2020 | $1,581,000 | +191.2% | 155,000 | 0.0% | 0.00% | – |
| Q3 2020 | $543,000 | -25.0% | 155,000 | +6.8% | 0.00% | -100.0% |
| Q2 2020 | $724,000 | +52.4% | 145,100 | +3.9% | 0.00% | 0.0% |
| Q1 2020 | $475,000 | – | 139,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |